Tolero Pharmaceuticals' Series B - II Round

Tolero Pharmaceuticals raised a round of funding on November 05, 2014. Investors include Fred Alger Management.

Tolero Pharmaceuticals is a biotechnology company specializing in the research and development of therapeutic agents in the areas of oncology and hematological disorders. Tolero possesses drug discove…

Articles about Tolero Pharmaceuticals' Series B - II Round: